U.S. Markets
Hims & Hers Health Inc. (HIMS) Q2 2026 (USD): EPS -0.37 (exp. -0.05), Revenue 753.2mln (exp. 699mln). Q3 revenue view 880-9000mln (exp. 792mln). FY revenue view 3.1-3.3bln (exp. 2.93bln).
StockNow breaking-news AI analysis
HIMS reported strong revenue growth and raised guidance, though a larger-than-expected EPS loss overshadowed the top-line beat and subscriber growth during Q2 2026.
News detail
Q2 subscribers 2.9mln (exp. 2.74mln).
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
